Structure |
Chemical Name |
CAS |
MF |
|
Sugammadex sodium Org199010-1 Impurity |
|
|
|
Cabozantinib impurity 53 |
|
|
|
Sugammadex sodium Org226100-1 Impurity |
|
|
|
1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole |
206050-24-0 |
C10H8ClF2N3 |
|
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
|
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
|
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
|
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
|
Aztreonam Impurity B |
102586-36-7 |
C13H19N5O6S |
|
Olopatadine impurity |
|
|
|
Voriconazole Impurity 8 |
239807-03-5 |
C16H14F3N5O |
|
Caspofungin impurity 3 |
|
|
|
Plerixafor Impurity D |
|
|
|
methyl 1-phenylethanesulfonate |
883835-57-2 |
C9H12O3S |
|
Cefuroxime impurity 1 |
|
C16H16N4O8S |
|
Vonoprazan Impurity 9 |
|
|
|
Sitagliptin IMpurity 5 |
|
|
|
Brexpiprazole Impurity3 |
|
|
|
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
|
Febuxostat Impurity B |
|
|
|
Sorafenib Impurity F |
|
|
|
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
|
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
|
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
|
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
|
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |
|
Vildagliptin Impurity 6 |
1846606-31-2 |
C17H23N3O2 |
|
Flucloxacillin Impurity A |
|
|
|
Nicorandil Impurity 1 |
|
|
|
Piperacillin Impurity 6 |
|
|
|
Bosutinib Impurity 5 |
1391063-17-4 |
C26H29Cl2N5O3 |
|
Levomilnacipran impurity |
|
|
|
Sofosbuvir IMpurity 4 |
|
|
|
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
|
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
|
2-(2-ピリジニルアミノ)グリオキシル酸エチル |
41374-72-5 |
C9H10N2O3 |
|
Canagliflozin Impurity 18 |
|
|
|
Canagliflozin Impurity 23 |
|
|
|
Doxofylline Impurity 22 |
|
|
|
Dapoxetine impurity 61 |
|
|
|
Dapoxetine impurity 55 |
|
|
|
1-METHYLBIGUANIDE SULPHATE |
1609-00-3 |
C3H9N5 |
|
1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE |
1246815-70-2 |
C12H18ClNO3 |
|
4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid |
110611-91-1 |
C71H110NO15P |
|
Oxacillin Impurity H |
|
|
|
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
|
Butyphthalide impurity 26 |
|
|
|
Butyphthalide impurity 32 |
|
|
|
Canagliflozin Impurity 30 |
|
|
|
Celecoxib Impurity 20 |
343853-74-7 |
C6H7N3O3S |
|
Emtricitabine Impurity CFTU1 |
|
|
|
Febuxostat Impurity 82 |
|
|
|
Febuxostat Impurity 87 |
|
|
|
Gefitinib Impurity R |
|
|
|
Cabozantinib impurity 75 |
|
|
|
Cabozantinib impurity 73 |
|
|
|
Canagliflozin Impurity 69 |
|
|
|
Dapoxetine impurity 65 |
|
|
|
Dapoxetine impurity 59 |
|
|
|
PeraMpanel |
380919-34-6 |
C23H17N3O2 |
|
Empagliflozin Impurity 83 |
|
|
|
Ambroxol Imp.O |
1807328-39-7 |
C13H12Br2N2O |
|
Carfilzomib Impurity 4 |
|
|
|
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
|
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
|
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
|
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
|
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
|
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
|
4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン |
1145671-52-8 |
C20H23N3O4 |
|
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
|
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
|
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
|
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
|
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
|
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
|
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
|
Rortezide impurity |
|
|
|
Cabozantinib Impurity A |
|
|
|
Loxoprofen Impurity E |
|
|
|
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
|
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
|
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
|
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
|
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
|
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
|
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
|
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
|
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
|
2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸 |
4818-85-3 |
C12H12N2O5S |
|
PeraMpanel |
380918-54-7 |
C23H15N3O |
|
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
|
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
|
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
|
3,5,7-トリメチル-1-アダマンタンアミン?塩酸塩 |
15210-60-3 |
C13H24ClN |
|
2,6-ジメチル-4-(2,3-ジクロロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-(ブチリルオキシメチル) |
188649-48-1 |
C21H21Cl2NO6 |
|
BIS VALACYCLOVIR (?90%) |
1356019-51-6 |
C27H40N12O8 |
|
Flupirtine DiMer |
1417916-52-9 |
C30H32F2N8O4 |
|
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |